SEPTInvestingStart Free

LXEO SCHEDULE 13G/A: SEC filing

Affinity Asset Advisors, LLC and Michael Cho

Filed with the SEC on · accession 0001011438-26-000696

LXEO filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 13, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -1.4% by the first close after the filing.

Summary of the filing

Affinity Asset Advisors, LLC and Michael Cho filed an amended Schedule 13G reporting beneficial ownership of approximately 9.8% of Lexeo Therapeutics' common stock, including shares issuable upon exercise of warrants, as of September 30, 2026.

For details, click here →

Key details

Shares beneficially owned$8.1M
Shares issuable upon exercise of warrants$867K
Total common stock outstanding$83.0M
Reporting person / investment managerAffinity Asset Advisors, LLC
Direct holder of the securitiesAffinity Healthcare Fund, LP
IssuerLexeo Therapeutics, Inc.
Managing member of affinity asset advisors, llcMichael Cho
Chief financial officer and chief compliance officer of affinity asset advisors, llcAndrew Weinstein

How LXEO stock reacted

Close before

$2.91

Nov 12, 2026

First close after

-1.37%

$2.87

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for LXEO, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for LXEO?

Click here

Frequently asked questions

What did LXEO file with the SEC on Nov 13, 2026?

LXEO filed a SCHEDULE 13G/A (SEC filing). Affinity Asset Advisors, LLC and Michael Cho filed an amended Schedule 13G reporting beneficial ownership of approximately 9.8% of Lexeo Therapeutics' common stock, including shares issuable upon exercise of warrants, as of September 30, 2026.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did LXEO stock react to this filing?

LXEO closed at $2.91 before the filing and $2.87 on Nov 13, 2026 (-1.37%).

Other LXEO SEC filings

Get alerts when LXEO files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
LXEO overviewLXEO analysisLXEO newsLatest SEC filings